| 國立臺灣大學 |
2005-01 |
HBV genotypes and outcome of HBV infection.
|
Kao, JH; Chen, DS. |
| 臺大學術典藏 |
2018-09-10T06:00:28Z |
HBV genotypes: Epidemiology and implications regarding natural history
|
Kao, J.-H.;Chen, D.-S.; DING-SHINN CHEN; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:18:58Z |
HBV genotypes: Epidemiology and implications regarding natural history
|
JIA-HORNG KAO; Chen D.-S. |
| 臺大學術典藏 |
2018-09-10T18:03:51Z |
HBV markers for HCC prediction: Three heads are better than two?
|
Tseng, T.-C.;Kao, J.-H.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-09-04T06:11:01Z |
HBV markers for HCC prediction: Three heads are better than two?
|
Tseng T.-C.; JIA-HORNG KAO |
| 中國醫藥大學 |
2006-04 |
HBV reactivated post chemotherapy
|
蔡金記; 廖光福; 余承儒; 鄭庚申; 彭成元 |
| 中國醫藥大學 |
2006-04-22 |
HBV reactivated post chemotherapy
|
蔡金記(Chin-Chi Tsai); 廖光福(Kuan-Fu Liao); 余承儒(Cheng-Ju Yu); 鄭庚申(Ken-Sheng Cheng); 彭成元(Cheng-Yuan Peng) |
| 國家衛生研究院 |
2009-04-20 |
HBV replication is significantly reduced by IL-6
|
Kuo, TM;Hu, CP;Chen, YL;Hong, MH;Jeng, KS;Liang, CC;Chen, ML;Chang, C |
| 東海大學 |
2009 |
HBV replication is significantly reduced by IL-6
|
Kuo T.M., Hu C., Chen Y.L., Hong M.H., Jeng K.S., Liang C.T., Chen M.L. and Chang C.; 胡承波 |
| 臺大學術典藏 |
2021-07-03T03:33:26Z |
HBV X protein-based therapeutic vaccine accelerates viral antigen clearance by mobilizing monocyte infiltration into the liver in HBV carrier mice
|
Horng J.-H.; Lin W.-H.; Wu C.-R.; Lin Y.-Y.; Wu L.-L.; Chen D.-S.; PEI-JER CHEN |
| 國立臺灣大學 |
1985 |
Hbv 母兒垂直感染δ抗原抗体檢討
|
林鶴雄; 大戶齊; 衛藤隆; 川名尚; 水野正彥; LIN, HO-HSIUNG; OHTO HITOSHI; ETOH TAKASHI; KAWANA TAKASHI; MASAHIKO MIZUNO |
| 國立臺灣大學 |
2015 |
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
|
Peng, Cheng-Yuan; Hsieh, Tsung-Cheng; Hsieh, Tsai-Yuan; Tseng, Kuo-Chih; Lin, Chih-Lin; Su, Tung-Hung; Tseng, Tai-Chung; Lin, Hans Hsienhong; Wang, Chia-Chi; Kao, Jia-Horng; 高嘉宏 |
| 臺大學術典藏 |
2021-03-09T01:47:38Z |
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
|
Peng C.-Y.; Hsieh T.-C.; Hsieh T.-Y.; Tseng K.-C.; Lin C.-L.; TUNG-HUNG SU; Tseng T.-C.; Lin H.H.; Wang C.-C.; Kao J.-H. |
| 臺大學術典藏 |
2021-09-04T06:11:28Z |
HBV-DNA level at 6 months of entecavir treatment predicts HBeAg loss in HBeAg-positive chronic hepatitis B patients
|
Peng C.-Y.; Hsieh T.-C.; Hsieh T.-Y.; Tseng K.-C.; Lin C.-L.; Su T.-H.; Tseng T.-C.; Lin H.H.; Wang C.-C.; JIA-HORNG KAO |
| 國立臺灣大學 |
2011 |
Hbv/a and Hbv/C Genotype Predominance among Patients with Chronic Hepatitis B Virus Infection in Cebu City, Philippines
|
曾岱宗; 高嘉宏; TSENG, TAI-CHUNG; KAO, JIA-HORNG |
| 臺大學術典藏 |
2018-09-10T08:44:44Z |
HBV/A and HBV/C genotype predominance among patients with chronic hepatitis B virus infection in Cebu City, Philippines
|
Chen, Pei-Jer; Chen, Ding-Shinn; Liu, Chun-Jen; 陳定信; 劉振驊; 楊宏志; 蘇東弘; 劉俊人; 陳培哲; 曾岱宗;高嘉宏; Batoctoy, K.S. and Tseng, T.-C. and Kao, J.-H. and Quiza, F.E. and Garcia Sr., L.H. and Lao-Tan, J.; Batoctoy, Karen S.; Tseng, Tai-Chung; Kao, Jia-Horng; Quiza, Fidelis E.; Garcia, Lamberto H.; Lao-Tan, Judy; Cheng, Huei-Ru; JIA-HORNG KAO; Kao, Jia-Horng; Batoctoy, Karen S.; Wu, Hui-Lin; Tseng, Tai-Chung; Liu, Chen-Hua; Kao, Jia-Horng; Yang, Hung-Chih; Lao-Tan, Judy; Quiza, Fidelis E.; Su, Tung-Hung; Garcia, Lamberto H. |
| 臺大學術典藏 |
2021-09-04T06:12:06Z |
HBV/A and HBV/C genotype predominance among patients with chronic hepatitis B virus infection in Cebu City, Philippines
|
Batoctoy K.S.; Tseng T.-C.; JIA-HORNG KAO; Quiza F.E.; Garcia Sr. L.H.; Lao-Tan J. |
| 國立臺灣大學 |
1983 |
HBVズ關エペ臨床シガソ解釋
|
川名尚; 林鶴雄; 川名尚; Lin, Ho-Hsiung |
| 國立臺灣大學 |
1985 |
HBV母兒垂直感染ズれんペチ抗原抗体ソ檢討
|
林鶴雄; 川名尚; 大戶齊; 水野正彥; 衛藤隆; Lin, Ho-Hsiung; 川名尚; 大戶齊; 水野正彥; 衛藤隆 |
| 國立臺灣大學 |
1985 |
HBV母兒感染對策
|
川名尚; 林鶴雄; 川名尚; Lin, Ho-Hsiung |
| 東海大學 |
2008-07 |
HBx inhibits the growth of CCL13-HBX-stable cells via the GSK-3beta/beta-catenin cascade.
|
黃光裕; Kuo, Chan-Yen; Wu, Cheng-Chung; Hsu, Shih-Lan; Hwang, Guang-Yuh |
| 東海大學 |
2008 |
HBx inhibits the growth of CCL13-HBX-stable cells via the GSK-3β/β-catenin cascade
|
Kuo, C.-Y.a, Wu, C.-C.b, Hsu, S.-L.c, Hwang, G.-Y. |
| 中國醫藥大學 |
2015-06-29 |
HBx sensitizes HCC cell lines to lapatinib by up-regulating ErbB3
|
陳貞妤(Jhen Yu Chen);陳韻如(Yun-Ju Chen);陳雯淑(Wen Shu Chen);黃偉謙(Wei-Chien Huang);黃偉謙(Wei-Chien Huang) |
| 義守大學 |
2016-01 |
HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3
|
Jhen-Yu Chen;Yun-Ju Chen;Chia-Jui Yen;Wen-Shu Chen;Wei-Chien Huang |
| 國立成功大學 |
2016-01-05 |
HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3
|
Chen, Jhen-Yu; Chen, Yun-Ju; Yen, Chia-Jui; Chen, Wen-Shu; Huang, Wei-Chien |
| 亞洲大學 |
2016-01 |
HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3.
|
陳貞妤(Chen, Jhen-Yu);Chen), 陳韻如(Yun-Ju;Yen), 顏家瑞(Chia-Jui;Chen), 陳雯淑(Wen-Shu;Huang)*, 黃偉謙(Wei-Chien |
| 亞洲大學 |
2016-01 |
HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3.
|
陳貞妤;Chen, Jhen-Yu;陳韻如;Chen, Yun-Ju;顏家瑞;Yen, Chia-Jui;陳雯淑;Chen, Wen-Shu;黃偉謙;Huang, Wei-Chien;* |
| 亞洲大學 |
2016-01 |
HBx sensitizes hepatocellular carcinoma cells to lapatinib by up-regulating ErbB3.
|
陳貞妤；Chen, Jhen-Yu；陳韻如；Yun-Ju Chen；顏家瑞；Chia-Jui Yen；陳雯淑；Wen-Shu Chen；黃偉謙；Wei-Chien Huang；* |
| 國立臺灣大學 |
2004 |
HBXAP及其交互作用之蛋白質的研究與探討
|
黃靜宜; Huang, Jing-Yi |
| 國家衛生研究院 |
2010 |
HBx基因轉殖鼠引發肝癌之基因體及蛋白質體的研究
|
喻秋華 |
| 國立臺灣大學 |
2016 |
HBx對細胞鈣離子恆定影響之研究
|
蔡沛儒; Tsai, Pei-Ju |
| 國立臺灣大學 |
2016 |
HBx經由IKKα/microRNA路徑抑制maspin表現促進肝癌惡化
|
陳雯淑; Chen, Wen-Shu |
| 東海大學 |
2008 |
HBx蛋白質透過GSK-3β/β-catenin訊息傳遞路徑抑制Chang-HBx(CCL13-HBx)穩定細胞株的生長
|
郭展延; Kuo, Chan-Yen |
| 中國醫藥大學 |
2017-08-22 |
HBx調控肝癌細胞中DDB2的表現與化療抗藥性的角色探討
|
林莉婕;Li-Jie Lin |
| 慈濟大學 |
2007 |
HBy基因對MSG2肝細胞轉型之影響
|
林玨羽 |
| 國立臺灣大學 |
1995 |
HBヨユюЗワчэヤ妊婦ソ取ベ扱ゆ
|
川名尚; 吉川裕之; 林鶴雄; 川名尚; 吉川裕之; Lin, Ho-Hsiung |
| 國立臺灣大學 |
1984 |
HB抗原, 抗体檢出法--ガソ臨床的意義シ新ウゆ檢查法
|
川名尚; 林鶴雄; 川名尚; Lin, Ho-Hsiung |
| 中原大學 |
2001 |
HCA與DEA方法之研究與應用
|
顧志遠 |
| 中國醫藥大學 |
2008-12-06 |
HCC Case Challenge Discussant
|
莊伯恒(Po-Heng Chuang) |
| 高雄醫學大學 |
2011 |
HCC Consensus-Prevention
|
黃志富 |
| 中國醫藥大學 |
2008-07-03 |
HCC developing at the puncture site after PEI and TACE-One case report
|
蔡金記(Chin-Chi Tsai); 周仁偉(Jen-Wei Chou); 賴學洲(Hsueh-Chou Lai); 徐章虎(Chang-Hu Hsu); 余承儒(Cheng-Ju Yu); 鄭庚申(Ken-Sheng Cheng); 蔡金記(Chin-Chi Tsai); 鄭庚申(Ken-Sheng Cheng) |
| 臺大學術典藏 |
2022-01-15T00:07:55Z |
HCC Etiology-Dependent Tumor Control Probability Model After Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Pooled Analysis of an Asian Liver Radiation Therapy Group Study
|
Kim, N.; Cheng, J. C.H.; Ohri, N.; Huang, W. Y.; Kimura, T.; Zeng, Z. C.; Lee, V. H.F.; Kay, C. S.; Seong, J. |
| 臺大學術典藏 |
2022-01-07T00:59:22Z |
HCC Etiology-Dependent Tumor Control Probability Model After Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Pooled Analysis of an Asian Liver Radiation Therapy Group Study
|
Kim N.; CHIA-HSIEN CHENG; Ohri N.; Huang W.Y.; Kimura T.; Zeng Z.C.; Lee V.H.F.; Kay C.S.; Seong J. |
| 臺大學術典藏 |
2021-09-04T05:17:08Z |
HCC risk in patients with HBV-related cirrhosis receiving nucleos(t)ide analogues therapy: Is HCC prevented or delayed?
|
Su T.-H.; Tseng T.-C.; JIA-HORNG KAO |
| 臺大學術典藏 |
2021-03-09T01:43:22Z |
HCC risk in patients with HBV-related cirrhosis receiving nucleos(t)ide analogues therapy: Is HCC prevented or delayed?
|
TUNG-HUNG SU; Tseng T.-C.; Kao J.-H. |
| 國立中山大學 |
2015-07-29 |
HCD 應用於行動購物 app 開發之研究
|
許俊翊 |
| 中山醫學大學 |
2003-07-01 |
hCDC5p pre-mRNA 剪接因子與結合蛋白C/EBP beta交互作用之研究
|
梁式賢 |
| 中山醫學大學 |
2003 |
hCDC5p pre-mRNA剪接因子與結合蛋白C/EBPd交互作用之研究
|
卓欣怡; Hsin-Yi Chao |
| 臺大學術典藏 |
2006 |
HCDD: Hierarchical Cluster- based Data Dissemination in Wireless Sensor Networks with Mobile Sink
|
Lin, Ching-Ju; Chou, Po-Lin; Chou, Cheng-Fu; Lin, Ching-Ju; Chou, Po-Lin; Chou, Cheng-Fu |
| 國立臺灣大學 |
2006 |
HCDD: Hierarchical Cluster- based Data Dissemination in Wireless Sensor Networks with Mobile Sink
|
Lin, Ching-Ju; Chou, Po-Lin; Chou, Cheng-Fu |
